A rectal suppository formulation designed to reduce inflammation in the lower bowel, supporting the treatment of chronic intestinal conditions while promoting relief from symptoms such as pain and rectal bleeding.
Indications:
- Ulcerative colitis (mild to moderate).
- Proctitis and proctosigmoiditis.
- Maintenance therapy to prevent recurrence of inflammation.
- Reduction of rectal pain, discomfort, and bleeding associated with inflammatory bowel disease.
Main Active Ingredient:
- Mesalazine (500 mg per suppository).
Precautions:
- Use only under medical supervision.
- Not recommended for individuals with known hypersensitivity to salicylates or mesalazine.
- Patients with kidney or liver impairment should use with caution.
- Avoid use during pregnancy or breastfeeding unless advised by a physician.
- Store in a cool, dry place away from direct sunlight.
Side Effects:
- Mild abdominal pain or cramps.
- Headache or dizziness.
- Local irritation or discomfort in the rectal area.
- Rare allergic skin reactions such as rash or itching.
- In very rare cases, kidney or liver function changes.
Drug-Drug Interactions:
- Anticoagulants (e.g., warfarin).
- Azathioprine, 6-mercaptopurine, or thioguanine.
- NSAIDs.
Mesalazine (500 mg), hard fat, lecithin (derived from soya oil)